Skip to content

Bladder irrigation with tap water to reduce antibiotic treatment for catheter-associated urinary tract infections

Bladder irrigation with tap water to reduce antibiotic treatment for catheter-associated urinary tract infections: a prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN16005365
Enrollment
58
Registered
2024-04-17
Start date
2022-07-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder irrigation (BI) with tap water to reduce antibiotic use for the treatment of catheter-associated urinary tract infection (CAUTI) in patients with urinary catheters in the community setting Infections and Infestations

Interventions

Bladder irrigation (BI) with tap water will be prescribed to patients with recurrent catheter-associated urinary tract infection (CAUTI) symptoms and is used for the treatment of CAUTIs without system

Sponsors

Erasmus MC
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with an indwelling catheter performing CIC 2. Recurrent CAUTI symptoms for which BI started

Exclusion criteria

Exclusion criteria: 1. Received BI with tap water solely for other reasons, such as prevention of catheter blockage or bladder stones, or treatment of hematuria 2. A history of surgical bladder reconstruction

Design outcomes

Primary

MeasureTime frame
The number of self-reported antibiotic treatments for catheter-associated urinary tract infections (CAUTIs) during 3 months, measured using a self-developed questionnaire at baseline and 3-months follow-up

Secondary

MeasureTime frame
The following secondary outcome measures will be assessed at baseline and 3-months follow-up: 1. Number of self-reported CAUTIs during 3 months measured using a self-developed questionnaire 2. Health-related quality of life measured using the EuroQoL EQ-5D-5L 3. Treatment satisfaction measured using the Treatment Satisfaction Questionnaire for Medication-9 items (TSQM-9)

Countries

Netherlands

Contacts

Public ContactFelice Van Veen
f.vanveen@erasmusmc.nl+316 25 67 73 37

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026